Dutch medtech that produces the Kaleido patch insulin pump.
| Date | Round | Amount |
|---|---|---|
| Jan 2026 | Series D Plus Dutch ViCentra added $13 million to its Series D, bringing it to $98 million, with ROM Utrecht Region and other Dutch investors to scale production and prepare its US launch. | $13M |
| Sep 2025 | Series D Plus ViCentra closed an $85 million Series D led by Innovation Industries to launch the Kaleido 2 patch pump in Europe and prepare its US entry. | $85M |
| Dec 2021 | Series C Dutch medtech ViCentra raised a EUR 65M Series C led by Partners in Equity to commercialise its Kaleido wearable insulin pump. | $76.7M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.